((自动化翻译由路透提供，请见免责声明 )) (更新)
11月26日 - ** 药物开发商Poseida Therapeutics 的股价上涨两倍多，达到9.28美元，为三年多来的最高价
** 瑞士罗氏控股公司 将以现金方式收购PSTX，交易价值高达15亿美元 (link)，该公司称
** PSTX表示，罗氏将支付每股9美元的现金，并根据未来的里程碑支付最多4美元的额外费用。
** 交易建立在2022年罗氏与Poseida在血癌CAR-T疗法方面的合作基础之上
** 预计交易将于 2025 年第一季度完成
** 如果算上本交易日的涨幅，PSTX公司的 股价 今年已上涨了一倍多。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.